West Family Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Sell
4,557
-2,217
-33% -$103K 0.08% 231
2025
Q4
$328K Sell
6,774
-2,468
-27% -$122K 0.08% 244
2025
Q3
$436K Buy
9,242
+190
+2% +$9.17K 0.1% 216
2025
Q2
$437K Buy
9,052
+3,105
+52% +$159K 0.11% 184
2025
Q1
$330K Sell
5,947
-1,392
-19% -$75.3K 0.12% 159
2024
Q4
$354K Buy
7,339
+1,120
+18% +$56.9K 0.12% 164
2024
Q3
$358K Buy
6,219
+2,079
+50% +$112K 0.12% 168
2024
Q2
$201K Sell
4,140
-164
-4% -$7.91K 0.06% 238
2024
Q1
$209K Hold
4,304
0.06% 240
2023
Q4
$214K Sell
4,304
-26
-0.6% -$1.27K 0.07% 212
2023
Q3
$232K Hold
4,330
0.08% 190
2023
Q2
$233K Sell
4,330
-32
-0.7% -$1.72K 0.09% 199
2023
Q1
$237K Hold
4,362
0.09% 162
2022
Q4
$211K Buy
+4,362
New +$191K 0.07% 208
2021
Q4
Sell
-7,366
Closed -$355K 368
2021
Q3
$355K Sell
7,366
-2,934
-28% -$149K 0.09% 188
2021
Q2
$542K Buy
+10,300
New +$537K 0.15% 121

Other funds holding SNY

West Family Investments's SNY Position: Q1 2026 in Review

West Family Investments reduced its Sanofi (SNY) stake by 33% in Q1 2026, selling an estimated $103K and leaving 4,557 shares worth $220K. The position accounts for 0.08% of the portfolio, ranked #231.

West Family Investments first reported a position in SNY in Q2 2021 and has held it in 16 quarters since. The position peaked at $542K in Q2 2021. 740 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • West Family Investments held 4,557 shares of Sanofi worth $220K as of Q1 2026.
  • West Family Investments sold 2,217 Sanofi shares in Q1 2026, an estimated $103K.
  • Sanofi made up 0.08% of West Family Investments's portfolio in Q1 2026, its #231 holding.
  • West Family Investments first reported a position in Sanofi in Q2 2021 and has held it in 16 quarters since.
  • West Family Investments's Sanofi position peaked at $542K in Q2 2021.
  • 740 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.